WebTo participate in Diakron which holds the worldwide rights for the compound. Orchid Chemicals & Pharmaceuticals Ltd., (“Orchid”), the Chennai (India) based pharmaceuticals major has announced that it would be undertaking the development and manufacture of an anti-coagulant drug candidate initially discovered and developed through Phase I by … WebDiakron Pharmaceuticals Inc PO Box 748 Morris Plains, New Jersey 07950-0748 Phone: 201.404.5705 Website Website Links Latest news Description Diakron Pharmaceuticals, Inc. is a cardiovascular drug development company focused on clinically differentiated products for significant cardiovascular markets.
Diakron Gets Exclusive Rights To Merck Anticoagulant
WebdigitGaps report on Diakron Pharmaceuticals Inc delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses … WebJapan is the second largest pharmaceutical market and the second highest healthcare spender. The pharmaceutical sales in the Japanese market increased by 3% from US$66.6 bn in 2007 to US$68.6 bn in 2008. The Japanese government is committed to increase the share of generics from the current low of 4% to as high as 30% in the years to come. slow hierarchy calculator
BioCentury - Diakron Pharmaceuticals Inc., Merck, Orchid …
WebNov 2, 2010 - Diakron Pharmaceuticals, Inc. Improved process for the preparation of 3-fluoro-2-pyridylmethyl-3-(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one-1-acetamide of formula (I) and its intermediates is provided. Latest … WebDiakron Pharmaceuticals, Inc. announced today the signing of an exclusive license agreement for a novel investigational oral anticoagulant drug candidate discovered and … WebJul 28, 2024 · Diakron Pharmaceuticals Dr. Reddy's Laboratories DuPont Merck Eisai Eli Lilly EMS Endo Laboratories ESP Pharma Eurofarma Fournier Pharma Gate Pharmaceuticals Genentech GlaxoSmithKline (GSK)... slo whi